Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?

Petcu EB, Ivanovski S, Wright RG, Slevin M, Miroiu RI, Brinzaniuc K.

Diagn Pathol. 2012 Jul 6;7:78. doi: 10.1186/1746-1596-7-78.

2.

[Vitamin D and bisphosphonate-related osteonecrosis of the jaw (BRONJ) ].

Hokugo A.

Clin Calcium. 2012 Jan;22(1):83-90. doi: CliCa12018390. Review. Japanese.

PMID:
22201103
3.

Effects of bisphosphonate treatment on DNA methylation in osteonecrosis of the jaw.

Polidoro S, Broccoletti R, Campanella G, Di Gaetano C, Menegatti E, Scoletta M, Lerda E, Matullo G, Vineis P, Berardi D, Scully C, Arduino PG.

Mutat Res. 2013 Oct 9;757(2):104-13. doi: 10.1016/j.mrgentox.2013.07.003. Epub 2013 Jul 24.

4.

Dental extraction as a risk factor for bisphosphonate related osteonecrosis of the jaw in cancer patients: an update.

Utreja A, Almas K, Javed F.

Odontostomatol Trop. 2013 Jun;36(142):38-46. Review.

PMID:
24073539
5.

A role for C-terminal cross-linking telopeptide (CTX) level to predict the development of bisphosphonate-related osteonecrosis of the jaws (BRONJ) following oral surgery?

O'Connell JE, Ikeagwani O, Kearns GJ.

Ir J Med Sci. 2012 Jun;181(2):237-42. doi: 10.1007/s11845-011-0790-5. Epub 2012 Jan 6.

PMID:
22223192
6.

Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.

Lazarovici TS, Mesilaty-Gross S, Vered I, Pariente C, Kanety H, Givol N, Yahalom R, Taicher S, Yarom N.

J Oral Maxillofac Surg. 2010 Sep;68(9):2241-7. doi: 10.1016/j.joms.2010.05.043.

PMID:
20728033
7.

The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data.

Allen MR, Burr DB.

J Oral Maxillofac Surg. 2009 May;67(5 Suppl):61-70. doi: 10.1016/j.joms.2009.01.007. Review.

PMID:
19371816
8.

Characteristics of bisphosphonate-related osteonecrosis of the jaw after kidney transplantation.

Park W, Lee SH, Park KR, Rho SH, Chung WY, Kim HJ.

J Craniofac Surg. 2012 Sep;23(5):e510-4. doi: 10.1097/SCS.0b013e31825b33f6.

PMID:
22976726
9.

Osteo-radio-necrosis (ORN) and bisphosphonate-related osteonecrosis of the jaws (BRONJ): the histopathological differences under the clinical similarities.

Mitsimponas KT, Moebius P, Amann K, Stockmann P, Schlegel KA, Neukam FW, Wehrhan F.

Int J Clin Exp Pathol. 2014 Jan 15;7(2):496-508. eCollection 2014.

10.

The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.

Carlson ER, Basile JD.

J Oral Maxillofac Surg. 2009 May;67(5 Suppl):85-95. doi: 10.1016/j.joms.2009.01.006.

PMID:
19371819
11.
12.

Incidence and risk factors of bisphosphonate-related osteonecrosis of the jaw in multiple myeloma patients having undergone autologous stem cell transplantation.

Then C, Hörauf N, Otto S, Pautke C, von Tresckow E, Röhnisch T, Baumann P, Schmidmaier R, Bumeder I, Oduncu FS.

Onkologie. 2012;35(11):658-64. doi: 10.1159/000343950. Epub 2012 Oct 22.

PMID:
23147542
13.

Intraoperative efficiency of fluorescence imaging by Visually Enhanced Lesion Scope (VELscope) in patients with bisphosphonate related osteonecrosis of the jaw (BRONJ).

Assaf AT, Zrnc TA, Riecke B, Wikner J, Zustin J, Friedrich RE, Heiland M, Smeets R, Gröbe A.

J Craniomaxillofac Surg. 2014 Jul;42(5):e157-64. doi: 10.1016/j.jcms.2013.07.014. Epub 2013 Sep 4.

PMID:
24011463
14.

Bridging the gap between osteoporosis and osteonecrosis of the jaw: preventing and treating BRONJ with MK4.

Neustadt J, Pieczenik S.

Compend Contin Educ Dent. 2011 Oct;32(8):e125-31. Review.

PMID:
23738523
15.
16.

Osteomalacia: the missing link in the pathogenesis of bisphosphonate-related osteonecrosis of the jaws?

Bedogni A, Saia G, Bettini G, Tronchet A, Totola A, Bedogni G, Tregnago P, Valenti MT, Bertoldo F, Ferronato G, Nocini PF, Blandamura S, Dalle Carbonare L.

Oncologist. 2012;17(8):1114-9. doi: 10.1634/theoncologist.2012-0141. Epub 2012 Jun 20.

17.

Bisphosphonate-related osteonecrosis: laser-assisted surgical treatment or conventional surgery?

Atalay B, Yalcin S, Emes Y, Aktas I, Aybar B, Issever H, Mandel NM, Cetin O, Oncu B.

Lasers Med Sci. 2011 Nov;26(6):815-23. doi: 10.1007/s10103-011-0974-2. Epub 2011 Aug 2.

PMID:
21809068
18.

Angiogenic suppression of osteoclasts may play a role in developing bisphosphonate-related osteonecrosis of the jaw.

Yin G, Bai Y, Luo E.

Med Hypotheses. 2011 Mar;76(3):347-9. doi: 10.1016/j.mehy.2010.10.036. Epub 2010 Nov 12.

PMID:
21074946
19.

[A case report - bisphosphonate-related osteonecrosis of the jaw(stage 0)successfully treated with sitafloxacin].

Ikeda T, Kohno N.

Gan To Kagaku Ryoho. 2012 Dec;39(13):2573-5. Japanese.

PMID:
23235183
20.

Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.

Vescovi P, Nammour S.

Minerva Stomatol. 2010 Apr;59(4):181-203, 204-13. Review. English, Italian.

PMID:
20360666

Supplemental Content

Support Center